• Gifts that give back

    Gifts for the Cure are real and meaningful gifts that you give to your family, friends, and co-workers for any special occasion, while also making an impact to those affected by cancer.

    Shop Now

  • Breast Cancer Futures Fund

    Support the Breast Cancer Futures Fund and create a lasting change in women’s health.

    Learn More

  • About Our Merger

    On February 1, 2017, the Canadian Cancer Society (CCS) and the Canadian Breast Cancer Foundation (CBCF) joined forces.

    Learn More

  • Canadian Cancer Statistics 2017

    Canadian Cancer Statistics 2017 was released on June 20. This annual publication gives detailed statistics for the most common types of cancer.

    Learn More

  • Breast Cancer Screening

    Need help understanding breast cancer screening and what you should do? We created an online decision aid tool to help inform all women of the factors to consider and their options. Give it a try.

    Try this tool

  • You Are Not Alone

    Whether you are living with metastatic breast cancer or have a loved one who is, it can be helpful to talk with someone who understands what you are going through. We are available to you.

    Learn More

  • Questions related to breast cancer?

    Our team has the latest information about breast cancer and can answer questions about a diagnosis, treatments, what to expect, financial resources, coping, local support groups and more.

    Learn More

You Are Here :
Home | Ontario | Your Dollars At Work | Research Saves Lives

Upcoming Events

Hot Topics

Corporate Partners & Sponsors

Research Saves Lives

The Canadian Breast Cancer Foundation (CBCF) is a national community-driven charity. As the largest charitable funder of breast cancer research in Canada, CBCF’s vision is to create a future without breast cancer. Since its inception in 1986, the Foundation has invested over $360 million in breast cancer research, funding more than 1,400 scientific and community grants. CBCF’s investments in vital research, education, health promotion, support and information programs have led to progress in breast cancer prevention, diagnosis, treatment and care.


Research Spotlight

Dr. Sheila Drover


Dr. Kiven Erique Lukong

One CBCF-funded researcher is taking a closer look at the epigenetic regulation of the tumour suppressor gene FRK in triple negative breast cancers. Read more


Other Research Grants

Dr. Sheila Drover, Associate Professor of Immunology in the Faculty of Medicine at Memorial University in St. John, NL, specializes in cancer immunity: finding new ways to help the body recognize and destroy its own cancer cells. Read more


Screening mammography is the best tool for the early detection of breast cancer. However, the British Columbia screening mammography rate is still below the national target of 70 per cent. Read more


Caregivers of breast cancer patients play a vital role. For male partners of women with breast cancer, research has shown that the demands of this responsibility can have a significant impact on their psychological well being. Read more


This is the question that Dr. Wendy Parulekar, from Queen’s University, and an international team of researchers are trying to answer. Since 2011, CBCF – Ontario has invested almost $900,000 in a large international trial of over 3,500 patients to determine whether metformin – a safe and inexpensive drug long used to treat type II diabetes – can reduce breast cancer recurrence and improve survival in women with early-stage breast cancer. Read more


Triple-negative breast cancer is a difficult-to-treat form of the disease that often has a poor prognosis, due to its aggressive nature and tendency to relapse and metastasize (spread). Although chemotherapy is the treatment of choice, these drugs may cause secondary cancers to develop, and they also have harmful side effects. Read more


Triple-negative breast cancer (TNBC) is an aggressive cancer that occurs globally in 400,000 women each year, often affecting younger people. It is much more aggressive than other cancers and is more likely to relapse and spread. A discovery made by a Canadian Breast Cancer Foundation – BC/Yukon Region funded research project has identified a protein critical to the survival of TNBC patients. Read more







More Information